| Literature DB >> 33842699 |
S N Chandana1, Fares Hezam Al-Ostoot2,3, Yasser Hussein Eissa Mohammed2,4, Tareq N Al-Ramadneh5, P Akhileshwari6, Shaukath Ara Khanum2, M A Sridhar6, B N Lakshminarayana1.
Abstract
Drug design is an integrated and developing system that portends an era of a novel and safe tailored drugs. It involves studying the effects of biologically active synthetic, semi-synthetic, and natural compounds based on molecular interactions in terms of molecular structure with activated functional groups or its unique physicochemical properties involved. The title compound, N-(2-aminophenyl)-2-(4-bromophenoxy) acetamide (c), was synthesized in a good yield and characterized by different spectroscopic techniques (Entities:
Keywords: 3D-interaction energies; DFT; Docking analysis; Hirshfeld surface; XRD
Year: 2021 PMID: 33842699 PMCID: PMC8020429 DOI: 10.1016/j.heliyon.2021.e06464
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Synthesis of the title compound (c).
Figure 21H NMR spectrum of synthesized compound (c).
Experimental data and structure refinement details.
| Molecular formula | C14 H13 Br N2 O2 |
| Molecular weight | 321.17 |
| Density | 1.613 Mgm−3 |
| Space group | |
| Crystal system | Orthorhombic |
| Wavelength and Radiation type | 0.71073Å and MoKα |
| θ range for data collection | 2.44o -28.32o |
| Unit cell parameters (Å) | |
| Volume (Å3) | 1322.5 (4) |
| Z | 4 |
| Temperature (K) | 296K |
| absorption coefficient μ(mm −1) | 3.107 |
| F000 | 648 |
| Crystal size (mm) | 0.22 × 0.21 × 0.20 |
| Diffractometer | Bruker D8 Quest Eco |
| T min, T min | 0.510, 0.537 |
| Reflections collected | 11923 |
| Data/restraints/parameters | 2871/1/172 |
| Data/restraints/parameters | 2871/1/172 |
| Index ranges | h = -13→13, k = -18→17, l = -8→12 |
| Refinement method | least-squares method |
| Goodness-of-Fit | 1.028 |
| R values | R1 = 0.0357,wR2 = 0.0777 |
| Δ | 0.27, -0.25 |
Figure 3ORTEP diagram of the molecule.
Figure 4Molecular packing viewed along a axis. and intermolecular interactions.
Docking energy scores (kcal/mol) derived from the MOE for the complex of MMP-2-c.
| Mol | Rseq | Mseq | S | Rmsd-Refine | E_Conf | E_Place | E_Score1 | E_ Refine | E_Score2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 1 | -7.4807 | 3.1178 | -10.5306 | -60.3399 | -9.0050 | -58.2949 | -7.4807 | |
| 2 | 1 | 1 | -6.9429 | 1.3521 | -12.6482 | -67.7620 | -8.6105 | -54.5694 | -6.9429 | |
| 3 | 1 | 1 | -6.8631 | 2.8109 | -10.2922 | -64.5918 | -8.6905 | -51.6884 | -6.8631 | |
| 4 | 1 | 1 | -6.5298 | 1.0206 | -8.0021 | -39.0260 | -9.3818 | -30.9748 | -6.5298 | |
| 5 | 1 | 1 | -6.4901 | 4.4836 | -11.8713 | -57.5256 | -8.7146 | -46.5586 | -6.4901 |
Figure 5a) MMP-2 interaction with compound (c) at the pocket site with residue amino acids in MMP-c complex. b) Ribbon diagram of the 1hov and the ligand as a complex molecule.
Figure 6a) The 2D interactions analysis of the title compound with MMP-2. b) 3D representation of the title compound in the active site of MMP-2. c) hydrogen-bond interaction view of the ligand molecule (title compound) with GLU121 and LEU83 in MMP-2 protein.
Figure 7a) The 3D Hirshfeld surface mapped on dnorm and b) electrostatic potential.
Figure 8Two-dimensional fingerprint plots of the compound (c).
Figure 9Color code mapping of a cluster's constituents with respect to reference molecule.
Figure 10Interaction energies (kJ/mole) of Molecular pairs.
Figure 11HOMO and LUMO
Global descriptive parameters and calculated energy values.
| Chemical parameters | Values |
|---|---|
| EHOMO | -5.8095eV |
| ELUMO | -0.4027eV |
| Egap (eV) | 5.406eV |
| Ionization potential(I) | 5.8095eV |
| Electron affinity(A) | 0.4027eV |
| Chemical hardness (η) | 2.703eV−1 |
| Global softness (σ) | 0.369eV |
| Chemical potential (μ) | -3.106eV |
| Electronegativity (χ) | 3.106eV |
| Electrophilicity (ω) | 1.784eV |